ENDRA Life Sciences (NDRA) Accumulated Depreciation & Amortization: 2016-2021
Historic Accumulated Depreciation & Amortization for ENDRA Life Sciences (NDRA) over the last 5 years, with Sep 2021 value amounting to $556,637.
- ENDRA Life Sciences' Accumulated Depreciation & Amortization rose 12.84% to $556,637 in Q3 2021 from the same period last year, while for Sep 2021 it was $2.1 million, marking a year-over-year increase of 12.40%. This contributed to the annual value of $506,660 for FY2020, which is 14.39% up from last year.
- As of Q3 2021, ENDRA Life Sciences' Accumulated Depreciation & Amortization stood at $556,637, which was up 5.66% from $526,814 recorded in Q2 2021.
- Over the past 5 years, ENDRA Life Sciences' Accumulated Depreciation & Amortization peaked at $556,637 during Q3 2021, and registered a low of $291,840 during Q1 2017.
- Its 3-year average for Accumulated Depreciation & Amortization is $479,412, with a median of $469,831 in 2020.
- Data for ENDRA Life Sciences' Accumulated Depreciation & Amortization shows a peak YoY rose of 22.26% (in 2017) over the last 5 years.
- ENDRA Life Sciences' Accumulated Depreciation & Amortization (Quarterly) stood at $337,630 in 2017, then increased by 20.23% to $405,946 in 2018, then increased by 9.11% to $442,928 in 2019, then increased by 14.39% to $506,660 in 2020, then increased by 12.84% to $556,637 in 2021.
- Its Accumulated Depreciation & Amortization stands at $556,637 for Q3 2021, versus $526,814 for Q2 2021 and $493,085 for Q1 2021.